Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Combined with Electroacupuncture for POCD in Elderly Patients
NCT02535039Phase 2Unknown
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Oct 2015
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) comparing Methylprednisolone + Electroacupuncture with Placebo + Electroacupuncture (2 arms). Primary endpoint: Montreal Cognitive Assessment at 1 day. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT02535039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535039.